%0 Journal Article
%T Pioglitazone’s beneficial effects on erectile function preservation after cavernosal nerve injury in the rat are negated by inhibition of the insulin-like growth factor-1 receptor: a preclinical study
%J -
%D 2018
%R https://doi.org/10.1038/s41443-018-0054-2
%X To determine if the insulin-like growth factor-1 (IGF-1) pathway is involved in the improvement in erectile function recovery in rats after nerve crush injury treated with pioglitazone (Pio). Sprague-Dawley rats were divided into four groups. The first group received sham operation (n？=？5). The second group underwent bilateral cavernous nerve injury (BCNI, n？？=？7). The third group received BCNI and Pio treatment (BCNI？？+？？Pio, n？=？7), whereas the fourth group underwent BCNI with Pio treatment and IGF-1 inhibition (BCNI？？+？？Pio？？+？？JB-1, n？=？7). The IGF-1 receptor (IGF-1R) was inhibited by JB-1, a small molecular antagonist of the receptor. After 14 days of treatment, erectile function was measured via intracorporal pressure normalized to mean arterial pressure (ICP/MAP) and the major pelvic ganglion and cavernous nerve harvested for western blot and immunohistochemistry (IHC) of phosphorylated-IGF-1Rβ (p-IGF-1Rβ), phosphorylated-ERK1/2 (p-ERK1/2), and neuronal NOS (nNOS). BCNI？？+？？Pio animals exhibited improvements in ICP/MAP, similar to Sham animals, and BCNI？？+？？Pio？？+？？JB-1 rats demonstrated a reduced ICP/MAP similar to BCNI-only rats at all measured voltages. Western blot results showed upregulation of p-IGF-1Rβ was observed in the BCNI？？+？？Pio group. Low levels of p-ERK1/2 were seen in the JB-1-treated animals. The immunoblot results were supported by IHC findings. Intense IHC staining of nNOS was detected in the BCNI？？+？？Pio group. The group treated with JB-1 showed minimal protein expression of p-ERK1/2, nNOS, and p-IGF-1Rβ. Pio improves erectile function in rats undergoing BCNI via an IGF-1-mediated pathway
%U https://www.nature.com/articles/s41443-018-0054-2